MO-BATS-GLOBAL-MARKETS
BATS Global Markets (BATS) today reported February volume, market share, and monthly highlights including its second best month on record for U.S. Options market share, which was 8.2%, up from 3.6% one year ago.
- In the U.S., February market share was 20.7%, up from 20.4% one year ago. Average daily matched volume on the BATS Exchanges was 1.41 billion shares vs 1.43 billion a year ago.
- In Europe, BATS Chi-X Europe – the region’s largest equities exchange – reported 23.7% overall market share. Average daily notional value traded was €12.3 billion, up substantially from €8.9bn in February 2014. Year-on-year, market share rose in 14 of the 15 markets BATS Chi-X Europe covers.
- BXTR, BATS Chi-X Europe’s trade reporting facility, had its second-most successful month ever with more than €369.3bn reported in total during February, an average of €18.5bn each trading day.
- On February 24th , BATS announced that Chris Concannon will be appointed to the additional role of chief executive officer , effective March 31, 2015. Joe Ratterman will assume the role of chairman of the BATS board.
- BATS welcomed two new exchange-traded funds (ETF) to its U.S. listings market. The KraneShares Emerging Markets Plus ETF commenced trading on February 17th and the iShares U.S. Fixed Income Balanced Risk ETF commenced trading on February 26th .
- On February 3rd , BATS announced that it had formally filed a petition for rulemaking on market structure reform with the Securities and Exchange Commission (SEC) and issued a call-to-action to the industry to drive regulatory reform.
- BATS continues to make progress towards the closing of its acquisition of the Hotspot FX market , with closing scheduled for March 13th .
February 2015 Volume and Market Share Summary
U.S. Equities (BATS Exchanges – BZX, BYX, EDGA, EDGX) | February 2015 | |||
Overall Industry – Average Daily Consolidated Volume | 6.79 billion shares | |||
BATS Exchanges – Matched Market Share | 20.7% | |||
BATS Exchanges – Average Daily Matched Volume | 1.41 billion shares | |||
U.S. Equity Options (BATS Options) | ||||
BATS Options – Matched Market Share | 8.2% | |||
BATS Options – Average Daily Matched Volume | 1,280,060 contracts | |||
European Equities (BATS Chi-X Europe) | ||||
Pan-European Consolidated Volume1 – Average Daily Notional Value | €52.2 billion | |||
BATS Chi-X Europe – Overall European Market Share | 23.7% | |||
BATS Chi-X Europe – Total Notional Value Traded | €246.8 billion | |||
BATS Chi-X Europe – Average Daily Notional Value | €12.3 billion | |||
European Trade Reporting (BXTR) | ||||
BXTR – Total Notional Value Reported | €369.3 billion | |||
BXTR – Average Daily Notional Value Reported | €18.5 billion |
1 Based on BATS Chi-X Europe market coverage, available at www.batstrading.co.uk
Additional details regarding BATS’ volume and market share data by market – U.S. equities, U.S. equity options, and European equities – is outlined below.
U.S. Equities – BATS Exchanges Volume and Market Share Statistics
Market Quality Statistics
- During February, the BZX Exchange ranked 1st or 2nd in quality of trading in 67% of the stocks in the S&P 500® Index, as measured by effective spread, according to the BATS market quality statistics .
- Combined, the BATS Exchanges – BYX, BZX, EDGA, EDGX – had the lowest effective spread in 25 of the top 50 exchange-traded products.
BATS Exchanges (BYX, BZX, EDGA, EDGX) – Market Volume Summary, Volume, and Statistics | ||||||||
February 2015 | February 2014 | |||||||
BATS Exchanges percentage of overall U.S. equities market share | 20.7% | 20.4% | ||||||
Average daily volume (ADV) traded on BATS Exchanges | 1.41 billion shares | 1.43 billion shares | ||||||
Total industry volume | 6.79 billion shares | 7.01 billion shares | ||||||
Total notional value traded on BATS Exchanges | $1.05 trillion | $1.1 trillion | ||||||
Average daily notional value traded on BATS Exchanges | $55.4 billion | $57.3 billion | ||||||
BATS overall market share – Tape A securities | 18.8% | 18.1% | ||||||
BATS overall market share – Tape B securities | 24.3% | 26.0% | ||||||
BATS overall market share – Tape C securities | 22.0% | 21.0% | ||||||
BATS overall market share in ETF trading2 | 24.4% | 26.6% | ||||||
BATS 1000 Index monthly performance and close |
+4.8%
23,365.95 |
+4.3%
20,979.74 |
2 Based on ArcaVision.com data
To track U.S. equities market share for all major trading exchanges and off-exchange trading, please view the BATS U.S. Equities Market Volume Summary .
U.S. Equity Options – BATS Options Volume and Market Share Statistics
- The five most actively-traded options classes on BATS Options during February were the Standard & Poor’s Depositary Receipt ETF Trust (SPY), Apple Inc. (APPL), iShares Russell 2000 Index ETF (IWM), Facebook Inc. (FB), and the iPath S&P 500 VIX Short-Term Futures ETN (VXX).
BATS Options Market Share and Volume | |||||||||||||
February 2015 | February 2014 | ||||||||||||
Contracts | Market share | Contracts | Market Share | ||||||||||
Average daily matched volume | 1,280,060 | 8.2% | 633,237 | 3.6% | |||||||||
To track U.S. options market share for all major trading exchanges, please view the BATS U.S. Options Market Volume Summary .
European Equities – BATS Chi-X Europe Volume and Market Share Statistics
To track European market share for all major trading exchanges and other venues, please view the BATS Pan-European Market Volume Summary .
BATS Chi-X Europe Market Share by Market 3 |
||||||||
February 2015 | February 2014 | |||||||
(In millions, except percentages) | ||||||||
BATS Chi-X Europe overall market share | 23.7% | 21.9% | ||||||
BATS Chi-X Europe Average daily notional value | €12,339.4 | €8,885.7 | ||||||
Displayed average daily notional value | €11,106.0 | €8,093.3 | ||||||
Non-displayed4 average daily notional value |
€1,233.4 | €792.4 | ||||||
London market overall | 24.4% | 23.7% | ||||||
FTSE 100 securities | 26.1% | 25.7% | ||||||
FTSE 250 securities | 23.1% | 21.7% | ||||||
Paris market overall | 27.3% | 22.4% | ||||||
CAC 40 securities | 28.2% | 23.6% | ||||||
CAC Next20 securities | 29.7% | 22.0% | ||||||
Frankfurt market overall | 26.5% | 23.7% | ||||||
DAX 30 securities | 27.9% | 25.9% | ||||||
MDAX securities | 29.5% | 20.4% | ||||||
TecDAX securities | 23.8% | 14.2% | ||||||
Amsterdam market overall | 26.3% | 21.2% | ||||||
AEX securities | 27.2% | 22.2% | ||||||
AMX securities | 22.2% | 15.8% | ||||||
Brussels market overall | 27.4% | 22.5% | ||||||
BEL 20 securities | 28.0% | 23.9% | ||||||
Milan market overall | 14.8% | 13.6% | ||||||
FTSE MIB securities | 15.6% | 14.9% | ||||||
Zurich market overall | 19.7% | 21.6% | ||||||
SMI securities | 21.2% | 23.6% | ||||||
SMIM securities | 21.1% | 18.4% | ||||||
Nordic market overall | 24.8% | 23.9% | ||||||
Helsinki OMXH25 securities | 27.1% | 25.4% | ||||||
Stockholm OMXS30 securities | 26.7% | 26.4% | ||||||
Copenhagen OMXC20 securities | 24.5% | 21.4% | ||||||
Oslo OBX securities | 22.5% | 23.4% | ||||||
Vienna market overall | 20.3% | 20.2% | ||||||
ATX securities | 21.2% | 20.8% | ||||||
Lisbon market overall | 14.5% | 9.6% | ||||||
PSI-20 securities | 14.7% | 9.9% | ||||||
Dublin market overall | 12.5% | 8.3% | ||||||
ISEQ 20 securities | 12.6% | 8.4 | ||||||
Madrid market overall | 19.1% | 18.3% | ||||||
IBEX 35 securities | 20.4% | 19.1% | ||||||
Key Indices | ||||||||
EUROSTOXX 50 securities | 24.6% | 23.3% | ||||||
FTSE RIOB | 7.0% | 8.2% |
3
Represent consolidated figures for BXE and CXE lit
and dark books, unless otherwise noted.
4
BXE
and CXE non-displayed order books.
About BATS Global Markets, Inc.
BATS Global Markets, Inc. is a leading global operator of securities markets, committed to Making Markets Better for traders, investors and issuers. In the U.S., BATS operates four stock exchanges – BZX, BYX, EDGX and EDGA – and regularly ranks as the top market for ETF and retail-driven liquidity. The company is an important listing venue for ETFs and other structured products and also operates BATS Options, a U.S. equity options market. In Europe, BATS operates the largest pan-European equities exchange, offering trading and listing services across 15 major European markets, as well as the largest pan-European trading facility, BXTR. With its world-class proprietary technology and relentless customer focus, BATS strives to bring efficiency, transparency and fairness to market participants. The company is headquartered in Kansas City with offices in New York, London and Chicago. Further information on BATS can be found at www.bats.com and by following us on Twitter @BATSGlobal .
Contact:
BATS
Randy Williams, +1.212.378.8522
Stacie Fleming,
+1.913.815.7193
Hannah Randall, +44.207.012.8950
comms@bats.com
Link:
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
30 Peer-Reviewed Studies Highlight Statistically Significant Health Benefits of Almased16.7.2025 09:15:00 CEST | Press release
Two recent, peer-reviewed clinical studies have found that Almased, a high-protein, low-glycemic meal replacement, delivers significant health benefits ranging from weight loss and improved metabolic health to anti-aging effects and enhanced quality of life. Both reviews synthesize 30 peer-reviewed clinical studies across three decades of scientific research, confirming that Almased is effective and safe for weight reduction, preservation of lean muscle mass, and cardiovascular health. The 2025 review in the American Journal of Biomedical Science & Research highlighted Almased’s efficacy and safety for wide groups of people including individuals seeking weight loss, those with metabolic syndrome or fatty liver, older adults needing to preserve muscle mass, and athletes or healthy-weight individuals who require additional high-quality protein. This review also discusses how Almased’s patented fermentation process produces over 80 bioactive peptides, including 2 times the average daily i
The Future of Connectivity Starts Here: Network X Returns to Paris October 14 - 1616.7.2025 09:00:00 CEST | Press release
Show Reconvenes at Paris Expo Porte de Versailles with Global Representation of Industry Leaders and Telco Experts Network X 2025 - the only event that brings the fixed and mobile markets together - returns to Paris Expo Porte de Versailles October 14 - 16. Built for telecom's top players, this annual show drives business model innovation and monetisation of next-generation fixed, mobile, satellite and transport networks through AI and cloud. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716595903/en/ Speaker on Headliners Stage at Network X 2024 New to Network X in 2025 are specialty events designed to deliver expert insights on trending topics including Data Center World and two Expo Stages for Fixed-Line and Mobile. More than 5,500 telco network infrastructure professionals will gather alongside 1,500 telcos to learn from six program tracks highlighting the latest advancements in Fibre, Wi-Fi Networks and Services, IP
Skechers AERO Series Opens New Chapter of Technical Running Innovation16.7.2025 09:00:00 CEST | Press release
New Collection Features an Evolution in Design that Cuts Through the Wind for That Aerodynamic Feel on Every Run Skechers Performance opens a new chapter of running innovation with the arrival of the Skechers AERO series. Named for the aerodynamic feel of the design, Skechers AERO represents the latest evolution of technical running shoes from the brand. The collection is engineered to deliver an exhilarating blend of speed, style and comfort to help runners cut through the wind and push beyond their personal bests while logging miles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716754749/en/ Introducing the Skechers AERO Series of technical running shoes: Skechers AERO Burst, Skechers AERO Spark, and Skechers AERO Tempo (L-R). “Recently launched in North America and Asia, the AERO Series leverages innovative technologies to elevate our signature comfort that’s now available to runners in Europe,” said Ben Stewart, Vic
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 07:00:00 CEST | Press release
- First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synovial health improvement via contrast-enhanced MRI - Topline results expected in the second half of 2026 4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P
Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 19:06:00 CEST | Press release
With Qi2.2 certification, Belkin reinforces its commitment to quality, safety, and performance for the next generation of wireless charging Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The comp
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum